Kathy Fosnaugh - Academia.edu (original) (raw)
Papers by Kathy Fosnaugh
Investigative Ophthalmology & Visual Science, 2005
Investigative Ophthalmology & Visual Science, 2004
本発明は,種々の用途,例えば,治療,診断,標的評価およびゲノム発見用途における使用において,ヒト免疫不全ウイルス(HIV)の遺伝子発現を調節するのに有用な方法および試薬に関する。詳細には,本発明... more 本発明は,種々の用途,例えば,治療,診断,標的評価およびゲノム発見用途における使用において,ヒト免疫不全ウイルス(HIV)の遺伝子発現を調節するのに有用な方法および試薬に関する。詳細には,本発明は,HIV遺伝子の発現および/または活性に対するRNA干渉(RNAi)を媒介しうる小核酸分子,例えば,短干渉核酸(siNA),短干渉RNA(siRNA),二本鎖RNA(dsRNA),マイクロRNA(miRNA),および短ヘアピンRNA(shRNA)分子に関する。小核酸分子は,HIV感染,AIDS,およびHIVの発現または活性の調節に応答する他の任意の疾病または病気の治療において有用である。
Cancer Research, 2017
Tumorigenesis is associated with increased polyamine levels and involves the induction of ornithi... more Tumorigenesis is associated with increased polyamine levels and involves the induction of ornithine decarboxylase (ODC), the initial rate-limiting enzyme in polyamine biosynthesis, and increased uptake of polyamines from the blood and diet. As well as contributing to proliferation, polyamines are reported to exert an immunosuppressive effect. Amplification of the MYC/MYCN oncogenes has been shown to directly induce ODC activity and inhibition of this enzyme by α-difluoromethylornithine (DFMO) markedly delays tumor development. Aminex Therapeutics is developing a polyamine depletion approach targeting both biosynthesis and transport of polyamines with AMX-513, a combination of the approved ODC inhibitor, DFMO, together with AMXT 1501, an alkylated polyamine mimetic which blocks polyamine uptake. In the syngeneic CT26.CL25 mouse model of colorectal cancer, AMX-513, dosed daily for four weeks, reduced tumor growth > 75% compared to vehicle-treated control in immunocompetent Balb/C m...
Molecular Therapy, 2011
Development of Amino Acid-based Liposomal siRNA Delivery Systems VII, apolipoprotein B100 (ApoB),... more Development of Amino Acid-based Liposomal siRNA Delivery Systems VII, apolipoprotein B100 (ApoB), and Transthyretin (TTR) genes are described.
Investigative Ophthalmology & Visual Science, 2005
Investigative Ophthalmology & Visual Science, 2004
本発明は,種々の用途,例えば,治療,診断,標的評価およびゲノム発見用途における使用において,ヒト免疫不全ウイルス(HIV)の遺伝子発現を調節するのに有用な方法および試薬に関する。詳細には,本発明... more 本発明は,種々の用途,例えば,治療,診断,標的評価およびゲノム発見用途における使用において,ヒト免疫不全ウイルス(HIV)の遺伝子発現を調節するのに有用な方法および試薬に関する。詳細には,本発明は,HIV遺伝子の発現および/または活性に対するRNA干渉(RNAi)を媒介しうる小核酸分子,例えば,短干渉核酸(siNA),短干渉RNA(siRNA),二本鎖RNA(dsRNA),マイクロRNA(miRNA),および短ヘアピンRNA(shRNA)分子に関する。小核酸分子は,HIV感染,AIDS,およびHIVの発現または活性の調節に応答する他の任意の疾病または病気の治療において有用である。
Cancer Research, 2017
Tumorigenesis is associated with increased polyamine levels and involves the induction of ornithi... more Tumorigenesis is associated with increased polyamine levels and involves the induction of ornithine decarboxylase (ODC), the initial rate-limiting enzyme in polyamine biosynthesis, and increased uptake of polyamines from the blood and diet. As well as contributing to proliferation, polyamines are reported to exert an immunosuppressive effect. Amplification of the MYC/MYCN oncogenes has been shown to directly induce ODC activity and inhibition of this enzyme by α-difluoromethylornithine (DFMO) markedly delays tumor development. Aminex Therapeutics is developing a polyamine depletion approach targeting both biosynthesis and transport of polyamines with AMX-513, a combination of the approved ODC inhibitor, DFMO, together with AMXT 1501, an alkylated polyamine mimetic which blocks polyamine uptake. In the syngeneic CT26.CL25 mouse model of colorectal cancer, AMX-513, dosed daily for four weeks, reduced tumor growth > 75% compared to vehicle-treated control in immunocompetent Balb/C m...
Molecular Therapy, 2011
Development of Amino Acid-based Liposomal siRNA Delivery Systems VII, apolipoprotein B100 (ApoB),... more Development of Amino Acid-based Liposomal siRNA Delivery Systems VII, apolipoprotein B100 (ApoB), and Transthyretin (TTR) genes are described.